Article
Eisai exec who helped steer Alzheimer's drug approval to leave
Rating:
0.0
Views:
35
Likes:
1
Library:
1
The Eisai executive who helped garner full U.S. approval for the Japanese drugmaker's Alzheimer's disease treatment Leqembi will retire at the end of this month, the company said on Tuesday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value